This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Zumutor Biologics Inc.. Active years: 2022-2025.
Location History:
- Karnataka Bangalore, IN (2022)
- Bengaluru, IN (2023)
Company Filing History:
Years Active: 2022-2025
Title: Nikitha Markanda: Innovator in Antibody Therapeutics
Introduction
Nikitha Markanda is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies for therapeutic applications. With a total of 3 patents to his name, Markanda is recognized for his innovative approaches to addressing complex medical challenges.
Latest Patents
Markanda's latest patents focus on antibodies that bind to C-type lectin domain family 2 member D (CLEC2D). The present disclosures relate to novel anti-CLEC2D antibodies and their related compositions and methods of use. These antibodies are utilized as therapeutics and have applications in prognostic and diagnostic settings for various cancers and other diseases. The potential of these antibodies to improve patient outcomes highlights the importance of his work in the medical field.
Career Highlights
Nikitha Markanda is currently associated with Zumutor Biologics Inc., where he continues to advance his research in antibody therapeutics. His work is characterized by a commitment to innovation and a focus on developing solutions that can significantly impact healthcare.
Collaborations
Some of his notable coworkers include Sathyabalan Murugesan and Ashvini Kumar Dubey, who contribute to the collaborative environment at Zumutor Biologics Inc. Their combined expertise fosters a culture of innovation and progress in the field of biotechnology.
Conclusion
Nikitha Markanda's contributions to the development of anti-CLEC2D antibodies exemplify the vital role of inventors in advancing medical science. His work not only enhances therapeutic options but also paves the way for future innovations in cancer treatment and diagnostics.